Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
About
Careers
Partners
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
About
Careers
Partners
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Diabetes
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Liraglutide for Obesity in Type 2 Diabetes
8
Mins
December 2023
Obesity is a major risk factor for the development of Type 2 diabetes (T2D), with the prevalence of both increasing in a parallel manner…
Read more
12
Mins
31st October 2017
Session Two: Changing the Type 2 Diabetes Mellitus Management Paradigm with Fixed-Ratio Combinations
Fixed-ratio combinations, the co-administration of two injectable therapies in a formulation that can be adjusted through titration, are changing the…
19
Mins
31st October 2017
Session Three: Innovating Beyond Glucose Control in Diabetes Care
Advances in treatment offerings are moving beyond classical considerations around glucose control to focus on other aspects of the disease.
10
Mins
31st October 2017
Editor’s Pick: Addressing Hypertension in the Patient with Type 2 Diabetes Mellitus: Pathogenesis, Goals, and Therapeutic Approach
Hypertension is considered a powerful cardiovascular risk factor and is present in up to two-thirds of patients who suffer from diabetes. In the…
10
Mins
31st October 2017
Future Treatments of Diabetic Retinopathy: Pharmacotherapeutic Products Under Development
Diabetic macular oedema (DMO) is the leading cause of vision loss in working aged individuals. Macular laser photocoagulation was the primary DMO…
8
Mins
31st October 2017
Role of Probiotics in Diabetes: A Review of Their Rationale and Efficacy
The efficacy of probiotics in diabetes has been proven by their ability to lower fasting glucose and insulin levels in a preclinical setting as well as in human trials.
9
Mins
31st October 2017
Type 2 Diabetes Mellitus and Stem Cell Therapy: A Review
Most public health statistics outline the rapidly exploding burden of Type 2 diabetes mellitus as a chronic endemic disease related to sedentary…
9
Mins
31st October 2017
Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Oedema: Is It Effective?
Diabetic macular oedema is a common ocular problem among patients with diabetic retinopathy, that is sight-threatening and leads to blindness
9
Mins
31st October 2017
Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Oedema: Is It Safe?
Over the last decade, intravitreal anti-vascular endothelial growth factor (anti-VEGF) agents have been increasingly used in the management of various…
Loading posts...
« Previous
1
…
9
10
11
12
13
…
16
Next »